FDA 483 - Chemolee Lab Corporation - May 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Chemolee Lab Corporation in Irving, TX, from May 19-30, 2025, revealed extensive deficiencies across its quality systems. The firm failed to establish an adequate Quality Unit, conduct proper annual product reviews, perform sufficient product testing and process validation, and maintain appropriate data integrity controls. These issues collectively indicate a severe lack of control over the manufacturing processes for their OTC drug products, compromising product quality and safety.
ID · a6548b91-5c4b-47a8-be1b-1f2d2c42b749